A Phase 3 study to evaluate the safety of an investigational varicella vaccine compared with Varivax, administered as a first dose to healthy children 12 to 15 months of age.
LULLABY
Current Studies
PG4-C4931008
A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a multivalent…
BEATRIX C1091009
A Phase 3, study to evaluate the safety, tolerability, and immunogenicity of…